Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Neoplasms 13 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 6 Lung Neoplasms 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Lymphoma 5 Stomach Neoplasms 4 Leukemia 4 Glioblastoma 4 Fatigue 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Motor Activity 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pain 2 Melanoma 2

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Analgesics, Opioid 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06555588 2026-03-16

Engage

Duke University

Phase NA Recruiting

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡